glp-1 updates 6-months off update : r/GLPGrad GLP-1 Trends: Access & Shortages,

Conclusion Oral GLP-1 therapy in 2026 represents a meaningful step forward in diabetes and obesity care

Metabolic Syndrome: A post hoc analysis revealed that patients achieving 15% weight loss had a significant decrease in the prevalence of metabolic syndrome, from 8091% at baseline to 2028% at Week 40/52

Let your healthcare provider know about all the medicines you take, as some medicines may contribute to hair loss

The posterior upper arm works but is harder to self-administer

Telehealth platforms connect you with licensed clinicians through virtual visits

Emerging agents like Tirzepatide, which activates both GLP-1 and GIP receptors, and Orforglipron, a nonpeptide oral GLP-1 agonist in phase 2 trials, further expand the therapeutic potential of this class (23)(24)